Michael Ip, MD

Articles by Michael Ip, MD

Rethinking OCT biomarkers in DME: Baseline acuity and thickness outperform the rest

ByMichael Ip, MD,Martin David Harp,Kassi Filkins

July 18th 2026

Michael Ip, MD, presented a large-scale analysis of OCT biomarkers in diabetic macular edema (DME), drawing on data from the DRCR Retina Network's Protocol T trial.

Latest Updated Articles

Rethinking OCT biomarkers in DME: Baseline acuity and thickness outperform the rest
July 18th 2026

Michael Ip, MD

Articles by Michael Ip, MD

Rethinking OCT biomarkers in DME: Baseline acuity and thickness outperform the rest

Latest Updated Articles

Trending on Eye Care Network - Ophthalmology Times

Frantz EyeCare LAL outcomes exceed national benchmarks in single-center cataract data